Estradiol Valerate/Medroxyprogesterone Acetate

戊酸雌二醇/醋酸甲羟孕酮

Report date: 2022/01/14 13:23:58

Base Information

Drug NameEstradiol Valerate/Medroxyprogesterone Acetate
Drug Alias NameMedroxyprogesterone Acetate/Estradiol Valerate醋酸甲羟孕酮/戊酸雌二醇DivinaDivina NovaDiviseq +[8] 
ClassificationSmall molecules > Steroids
Mechanisms of ActionProgesterone receptor agonistsEstrogen receptors agonists
TargetsEstrogen receptorsProgesterone receptor
Therapy Area/IndicationsEndocrine System DiseasesOsteoporosis
Global Approved IndicationsEndocrine System DiseasesOsteoporosis
Approved Indications in ChinaN/A
Original Approved Country/TerritoryFrance
Original Approved Date1984/01/01
Country/TerritoryFrance
CombinationsYes Estradiol ValerateMedroxyprogesterone Acetate
Global Highest StatusApproved
Highest Status in ChinaN/A
Originator CompaniesOrion Corp
China Registration ClassN/A

Develop Information

Active CompaniesOrion Corp
Inactive CompaniesN/A
Active IndicationsEndocrine System DiseasesOsteoporosis
Inactive IndicationsN/A

Other Information

ATC CodeG03FA12G03FB06
Related LinksN/A